Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Articles and Publications
Case Studies
Charge Capture and Pricing
Coding Integrity
Craneware Insights Articles
News & Events
Press Releases
Trade Shows
Upcoming Events
Value Cycle
White Papers

Trading Update and Notice of Results

2 July 2012 – Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market provides an update on trading for the year ended 30 June 2012.

Trading Update

The Group continues to make positive progress with a number of large opportunities identified at the time of the interim results, however no further large deals have closed in the financial year. Consequently the Board expects to report revenue for the year in the region of $41m (FY11: $38.1m) and adjusted EBITDA* approximately 15% higher than the previous year (FY11: $10.1m).This is below current consensus of market expectations for the year.

As announced at the time of the interim results, the Group’s performance has been impacted by an unexpectedly high percentage of healthcare providers focusing on Electronic Health Records. As a result, sales cycles extended for all the Group’s products in the first half of the year. However, increased month on month activity and sales levels in the second half of this year support the Board’s expectation that sales cycles are returning to normal lengths.

Medicare Recovery Auditors continue to add pressure on all US hospitals as over payments being recovered from hospitals increase quarter on quarter. As a result, the Board believes hospitals will continue to refocus on Revenue Integrity Solutions to rectify the underlying causes of the Medicare Recovery Auditors’ findings as well as to provide a strong underlying return on invested capital.

Keith Neilson, CEO of Craneware plc commented “This has been a mixed trading year for the Group; however we are in a stronger position than we have ever been. Our sales and opportunity pipeline continues to build, supported by a market that is refocusing on the problems our products can help solve. This combined with the acknowledged quality of our product suite and our balance sheet strength, means we are well placed to help our customers deal with their increasing fiscal and regulatory pressures and as a result we continue to be confident in the future growth of the Group.”

Notice of Results

Craneware will be announcing its preliminary results for the year ended 30 June 2012 on Tuesday 4 September 2012.

*adjusted EBITDA is profit before share based payments, depreciation, amortization and acquisition related costs.

For further information, please contact:

Craneware plc

  • +44 (0) 131 550 3100
  • Keith Neilson, CEO
  • Craig Preston, CFO

Peel Hunt

  • +44 (0) 20 7418 8900
  • Dan Webster
  • Richard Kauffer

Threadneedle Communications

  • +44 (0) 20 7653 9850
  • Caroline Evans-Jones
  • Fiona Conroy

About Craneware

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 220 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware’s market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit

The above documents and information on this website are provided to you for informational purposes only and additional information is available on request.None of the documents or information on this website constitute a solicitation, offer,opinion or recommendation to buy or sell any security, or to provide any legal,tax, accounting or investment advice or services regarding the profitability or suitability of any security or investment, nor is it intended for use by, or distribution to, any person or entity in any country or jurisdiction wheresuch use or distribution would be contrary to law or regulation.

None of the securities of Craneware plc have been nor will they beregistered under the US Securities Act of 1933, as amended (the “US Securities Act“) or any relevant securities laws of any state or other jurisdiction of the United States of America or any state, province or territory of Canada, Australia, New Zealand and Japan and may not be offered or sold inthe United States of America unless they are registered under the US Securities Act or an exemption from registration is available.

Any opinions or estimates expressed in the documents or on this website may be subject to change without notice and Craneware plc is under no to update its opinions, estimates or other information contained in the documents or on this website. Neither Craneware plc nor any of its affiliates accept any liability whatsoever for any direct or consequential loss arising from any use of any of the documents, their contents, or the contents of this website. Please remember that past performance is not necessarily a guide for future performance. The value of instruments and the income from them can go down as well as up.

Overseas Persons

In certain jurisdictions viewing the documents and the information on this website may be unlawful or restricted to certain categories of person.If you are not permitted or are in any doubt as to whether you are permitted to view materials on this website, please exit this webpage.

Skip to toolbar